We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACGN
12101
DELISTED
Aceragen Inc
ACGN
$186K ﹤0.01%
9,113
-3,746
-29% -$75.4K
BW icon
12102
PUT
Babcock & Wilcox
BW
$1.53B
$185K ﹤0.01%
23,500
+2,000
+9% +$16.5K
CLIR icon
12103
CALL
ClearSign Technologies
CLIR
$31.7M
$185K ﹤0.01%
3,850
-1,820
-32% -$86.1K
KYN icon
12104
CALL
Kayne Anderson Energy Infrastructure Fund
KYN
$2.51B
$185K ﹤0.01%
20,800
-3,100
-13% -$24.9K
VTSI icon
12105
VirTra
VTSI
$36.6M
$185K ﹤0.01%
+25,161
New +$148K
TTOO
12106
CALL
DELISTED
T2 Biosystems, Inc
TTOO
$185K ﹤0.01%
31
+1
+3% +$6.46K
PCPC.WS
12107
DELISTED
Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75
PCPC.WS
$185K ﹤0.01%
86,312
-110,449
-56% -$207K
LEAP
12108
CALL
DELISTED
Ribbit LEAP, Ltd.
LEAP
$185K ﹤0.01%
+17,300
New +$187K
AYTU icon
12109
CALL
AYTU BioPharma
AYTU
$25.5M
$184K ﹤0.01%
+1,840
New +$216K
ETON icon
12110
CALL
Eton Pharmaceutcials
ETON
$1.68B
$184K ﹤0.01%
+29,800
New +$221K
SDIV icon
12111
CALL
Global X SuperDividend ETF
SDIV
$1.21B
$184K ﹤0.01%
4,333
-3,367
-44% -$144K
TLSIW icon
12112
TriSalus Life Sciences Warrant
TLSIW
$18.1M
$184K ﹤0.01%
185,587
-338
-0.2% -$334
HNP
12113
PUT
DELISTED
Huaneng Power Intl, Inc.
HNP
$184K ﹤0.01%
+11,600
New +$170K
ENBL
12114
PUT
DELISTED
ENABLE MIDSTREAM PARTNERS, LP
ENBL
$184K ﹤0.01%
20,200
-17,500
-46% -$143K
BSQR
12115
CALL
DELISTED
BSQUARE Corporation
BSQR
$184K ﹤0.01%
+38,600
New +$102K
ACRS icon
12116
PUT
Aclaris Therapeutics
ACRS
$851M
$183K ﹤0.01%
10,400
-21,600
-68% -$491K
CVEO icon
12117
PUT
Civeo
CVEO
$344M
$183K ﹤0.01%
+10,300
New +$172K
INOD icon
12118
Innodata
INOD
$2.09B
$183K ﹤0.01%
26,062
-12,471
-32% -$84.5K
MBIO icon
12119
CALL
Mustang Bio
MBIO
$4.5M
$183K ﹤0.01%
73
-56
-43% -$137K
TRUE
12120
CALL
DELISTED
TrueCar
TRUE
$183K ﹤0.01%
32,300
+16,100
+99% +$81.1K
ORKA
12121
Oruka Therapeutics
ORKA
$7.35B
$183K ﹤0.01%
4,349
+2,749
+172% +$115K
QTNT
12122
DELISTED
Quotient Limited Ordinary Shares
QTNT
$183K ﹤0.01%
1,259
+702
+126% +$112K
SPNV.U
12123
DELISTED
Supernova Partners Acquisition Company, Inc. Units, each consisting of one share of Class A common s
SPNV.U
$183K ﹤0.01%
17,523
+3,773
+27% +$39.5K
HDSN
12124
CALL
Hudson Technologies
HDSN
$239M
$182K ﹤0.01%
53,400
+24,800
+87% +$59.8K
SPDN icon
12125
PUT
Direxion Daily S&P 500 Bear 1X ETF
SPDN
$198M
$182K ﹤0.01%
+11,500
New +$188K
483 484
485
486 487

Similar funds

Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Ken Griffin's Q2 2021 Portfolio in Review

As of Q2 2021, Ken Griffin held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Ken Griffin's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Ken Griffin's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Ken Griffin added most to AT&T in Q2 2021, an estimated $877M increase.
  • Ken Griffin's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Ken Griffin fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Ken Griffin's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Ken Griffin opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Ken Griffin's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.